Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Investors often wonder when the divisor resets after a stock split and what this means for index values. This intro clarifies the timing and practical implications for benchmarks.
22,047 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
MARA Holdings sold roughly 15,133 BTC for $1.1 billion to buy back convertible notes and trim debt, a move that reduc...
Bitcoin has endured bear markets and hype cycles alike, and its leadership shows in more than price. Here are four en...
The National Taxpayer Advocate says tens millions taxpayers owed refunds or relief may be available due to COVID-era ...
Kick off your week with a curated list of investing insights. These Monday reads translate market noise into actionab...
JPMorgan and Mastercard joined Ripple and Ondo Finance to settle a tokenized US Treasury redemption on the XRP Ledger...
Lime, the e-scooter and e-bike maker backed by Uber, aims for a 2026 IPO, even as mounting debt and a tighter funding...
When Occidental Petroleum faced a retreat in stock price, traders asked whether it was a one-off event or a signal. T...
Poppi’s journey shows how founders turn personal risk into billion-dollar exits. The cofounder maxed credit and even ...
A bold take from Amazon's CEO on the AI era could shift how investors price the stock. This guide breaks down what an...
Rising internal strife and political pressure push the FDA toward leadership change, with markets watching how the ag...
A working-class manager confronts a debt trap after purchasing a costly vehicle on a modest salary, underscoring how ...